logo
Select company
Select metric
$ -190.77MConsolidated Income
VS
Market
7
Sector
11
Industry
15
History
-
$ 43.37Close
$ 8.76 - $ 44.16 52-Week Range
Ticker Information

Ticker

MLYS

Company Name

MINERALYS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MINERALYS THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MLYS - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -190.77M
3/31/2025$ -188.51M
12/31/2024$ -177.81M
9/30/2024$ -153.25M
6/30/2024$ -119.67M
3/31/2024$ -90.8M
12/31/2023$ -71.9M
9/30/2023$ -56.58M
12/31/2022$ -29.8M
12/31/2021$ -19.41M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MINERALYS THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -19.41M.
  • Over the past 5 years, MINERALYS THERAPEUTICS INC's average Cons. Inc. has been $ -109.85M.
  • The median Cons. Inc. for MINERALYS THERAPEUTICS INC during this period was $ -105.23M
  • MINERALYS THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -19.41M.
  • The lowest Cons. Inc. recorded by MINERALYS THERAPEUTICS INC in the same timeframe $ -190.77M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

MLYS - Consolidated Income, Last 5 years

$ -190.77M

Minimum

Jun 30, 2025

$ -19.41M

Maximum

Dec 31, 2021

$ -109.85M

Average

$ -105.23M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.01M with a standard deviation of $ 116.51M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.01M
median$ -2.1M
std$ 116.51M